GoodRx Mounjaro: Breaking Down the Real Cost

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Welcome to the PlexusDx Education Hub, where we translate GLP-1 science, weight-management options, and the genetic signals underneath them into plain language. Browse the full Peptides & GLP-1 library.

Search "GoodRx Mounjaro" and you are trying to make sense of a confusing spread of prices — coupon quotes, list prices, insurance figures — that rarely agree. This guide untangles what actually drives Mounjaro's cost as of April 2026: the published list price, how insurance and prior authorization factor in, where savings cards and discount platforms fit, and what the compounding landscape looks like now.

Mounjaro's list price as of April 2026

Mounjaro's U.S. list price is approximately $1,069 per month as of April 2026, per Eli Lilly published pricing. That number is rarely what an insured patient pays at the counter — it is the starting point before insurance, rebates, manufacturer savings cards, and pharmacy negotiation come into play. Your actual out-of-pocket cost depends on your plan, its formulary, prior authorization, and the indication written on the prescription.

Insurance and prior authorization

Whether a commercial plan covers Mounjaro turns on the FDA-approved indication on the prescription plus that plan's formulary and prior authorization rules. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while coverage for chronic weight management varies far more widely, often hinges on BMI-based prior authorization, and is excluded entirely by some plans. Medicare does not cover FDA-approved weight-management drugs for weight alone as of April 2026, though cardiovascular-indication coverage exists for some products. Confirm details directly with your plan.

Savings cards and discount platforms

Eli Lilly publishes a manufacturer savings card that can substantially lower monthly out-of-pocket cost for eligible commercially-insured patients. Eligibility typically excludes Medicare, Medicaid, TRICARE, and other government-funded insurance, and the cards carry monthly and annual caps with terms that change — verify on the manufacturer website at the time of fill. Independent discount platforms such as GoodRx and SingleCare also publish coupon prices, and those vary by pharmacy.

What shifted in the compounding landscape

During FDA-declared shortages of semaglutide and tirzepatide, 503A compounding pharmacies legally produced compounded formulations of these molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, narrowing — though not eliminating — legitimate compounding activity. Compounded semaglutide and tirzepatide remain available through licensed pathways where clinically justified, but they are not identical to the FDA-approved brand products and are priced separately.

What real out-of-pocket scenarios look like

The range is wide. With commercial insurance that covers the indication and a savings card applied, eligible patients may pay as little as $25 per month, depending on plan terms and caps. With commercial insurance that does not cover the indication, cash cost lands closer to list price minus any coupon. Without insurance, cash-pay approaches list price, while compounded alternatives through PlexusDx Weight Management Protocols follow a separate pricing structure published on each product page.

The genetic context under the price question

Cost aside, the biology underneath any GLP-1 decision is worth understanding first. Variants in FTO, GLP1R, and MC4R shape baseline appetite, incretin signaling, and energy balance. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights across these traits — educational trait mapping, never a pharmacogenomic prediction of drug response. PlexusDx offers semaglutide and tirzepatide via 503A protocols, including Tirzepatide Injection.

More on PlexusDx: Mounjaro Generic and Mounjaro without Insurance.

Why the quoted prices never seem to agree

The reason a coupon price, a list price, and an insurance quote for Mounjaro rarely line up is that each answers a different question. List price is the manufacturer's starting number before anything is applied. A discount-platform coupon reflects a cash price negotiated at a particular pharmacy. An insurance figure depends on your plan, its formulary, prior authorization, and the indication on the prescription. None of them is wrong; they are simply measuring different points in the same pricing system. Knowing which number you are looking at — and confirming the current figure at the pharmacy before you fill — is what keeps the confusion from turning into an unwelcome surprise at the counter.

Frequently Asked Questions

How much does Mounjaro cost per month?

Mounjaro's U.S. list price is approximately $1,069 per month as of April 2026, per Eli Lilly published pricing. Insurance, savings cards, and pharmacy pricing can substantially change what a patient actually pays at the counter, so confirm the current price with the pharmacy before you fill the prescription.

Does insurance cover Mounjaro?

It depends on the plan, formulary, the FDA indication on the prescription, and prior authorization criteria. Many commercial plans cover GLP-1 receptor agonists for type 2 diabetes, while chronic weight management coverage is more variable. Medicare does not cover weight-management indications for weight alone as of April 2026.

Are there GoodRx coupons or savings cards for Mounjaro?

Eli Lilly publishes a manufacturer savings card for commercially-insured patients who meet eligibility criteria, and independent platforms like GoodRx and SingleCare publish discount prices that vary by pharmacy. Government-insurance patients are typically excluded from manufacturer cards. Check the manufacturer site at the time of fill for current terms.

Are there lower-cost alternatives to Mounjaro?

Licensed compounding pharmacies produce compounded semaglutide and tirzepatide formulations at price points separate from the FDA-approved brand products, though these are legally and factually different — not identical and not generics. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols with per-protocol pricing published on each product page.

Keep exploring inside the PlexusDx Education Hub. Return to all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.